SCHEMBL2992222

SCHEMBL2992222

COc1ccc(NC(=O)C(C)(C)N)cc1NS(=O)(=O)c1ccc(Br)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.52
KDM4E B2RXH2 4/20 0.52
KMT2A Q03164 9/20 0.51
LMNA P02545 7/20 0.51
MAPT P10636 5/20 0.51
HPGD P15428 1/20 0.51
MEN1 O00255 7/20 0.48
POLB P06746 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 2/20 0.45
USP2 O75604 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX12 P18054 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2983460 0.87 ALDH1A1 (0.53) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL4664122 0.82 ALDH1A1 (0.47) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL13245951 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL2990066 0.81 LMNA (0.64) ALDH1A1KMT2ALMNAMAPTMEN1
SCHEMBL13267539 0.80 ALDH1A1 (0.44) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL2991423 0.79 ALDH1A1 (0.50) ALDH1A1KMT2ALMNAMAPTMEN1
SCHEMBL2986118 0.77 ACLY (0.53) ALDH1A1KMT2ALMNAMAPTMEN1
SCHEMBL13245973 0.77 GHSR (0.54) ALDH1A1KDM4EKMT2ALMNAMAPT
Hydrochloric Acid SCHEMBL2991778 0.76 GHSR (0.54) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL4664203 0.75 GHSR (0.44) ALDH1A1KDM4EKMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed
EP-2007716-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 EP disclosed
WO-2007118852-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR ALDH1A1 2521/4885KDM4E 3009/4885KMT2A 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.